Snapshot

DOI:

EuroIntervention: focussing on clinical practice through the latest data and techniques such as managing pulmonary embolisms, antithrombotic monotherapy, CAS- and CEA-related outcomes and more

There is always a lot going on in our field – and just keeping up with the latest research can sometimes seem like a full-time job. We are here to help, and that’s why we often provide you with state-of-the-art and expert reviews as well as touching on a vast range of topics, for instance, in this issue, from outcomes in carotid artery interventions to an interesting approach to using crushed prasugrel in STEMI patients and much more. Read on, and I am sure you will find something of interest!

Percutaneous treatment of pulmonary embolism

Simone Finocchiaro, Davide Capodanno and colleagues offer a state-of-the-art review of emerging percutaneous interventional procedures for pulmonary embolism, including catheter-directed thrombolysis and mechanical thrombectomy, providing guidance on the selection of patients and the appropriate treatments.

See page e408

Efficacy of antithrombotic monotherapy according to revascularisation

Takashi Noda, Satoshi Yasuda and colleagues demonstrate that rivaroxaban monotherapy had favourable safety and efficacy outcomes over combination therapy in high thrombotic risk patients with a history of prior revascularisation in this post hoc analysis of the AFIRE trial.

See page e425

Crushed prasugrel loading dose in STEMI patients

Jeroen M. Wilschut, Roberto Diletti and colleagues investigate if patients with a large myocardial infarction benefit from prehospital administration of a crushed prasugrel loading dose. Improvements in postprocedural TIMI 3 flow after receiving the crushed loading dose led the authors to believe this may be a rapid and cost- effective strategy to improve myocardial perfusion.

See page e436

Comparison of carotid artery stenting- and carotid endarterectomy-related outcomes

Alberto Bramucci, Fausto Castriota and colleagues compare carotid endarterectomy and carotid artery stenting for the treatment of extracranial carotid artery stenosis. Carotid artery stenting has developed on both the surgical and endovascular fronts, and the authors find the 30-day outcomes for stroke, acute myocardial infarction, and death to be similar for both carotid artery stenting and carotid endarterectomy.

See page e445

Volume 20 Number 7
Apr 1, 2024
Volume 20 Number 7
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00029 Aug 4, 2025
Coronary sinus Reducer for the treatment of refractory angina: how much more evidence do we need?
Al-Lamee R and Foley M
free

Expert Review

10.4244/EIJ-D-24-00812 Aug 4, 2025
Management of device embolisation during left atrial appendage closure
Kefer J et al
free

Research Correspondence

10.4244/EIJ-D-24-01123 Aug 4, 2025
Coronary sinus narrowing for the treatment of refractory angina: one-year results of the REDUCER-I study
Verheye S et al

Editorial

10.4244/EIJ-E-25-00030 Aug 4, 2025
Expanding the boundaries of M-TEER: is it time to treat moderate secondary mitral regurgitation?
Adamo M and Riccardi M
free

Original Research

10.4244/EIJ-D-24-01174 Aug 4, 2025
Transcatheter valve repair of tricuspid regurgitation: 1-year outcomes from the TriCLASP study
Baldus S et al

Editorial

10.4244/EIJ-E-25-00035 Aug 4, 2025
The promise and pitfalls of registries for transcatheter tricuspid valve intervention
Hahn R
free
Trending articles
224

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.65

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
81.65

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
49.6

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.6

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
28.75

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved